Published in Lancet on April 06, 1991
Abnormal glycine metabolism in motor neurone disease: studies on plasma and cerebrospinal fluid. J R Soc Med (1993) 0.77
Gold therapy and neurological complications. Lancet (1991) 0.75
A report--chronic fatigue syndrome: guidelines for research. J R Soc Med (1991) 7.70
Comparison of the complete nucleotide sequences of the genomes of the neurovirulent poliovirus P3/Leon/37 and its attenuated Sabin vaccine derivative P3/Leon 12a1b. Proc Natl Acad Sci U S A (1984) 3.98
The complete nucleotide sequence of a common cold virus: human rhinovirus 14. Nucleic Acids Res (1984) 3.85
An oral preparation to release drugs in the human colon. Br J Clin Pharmacol (1982) 3.49
Amplification of rhinovirus specific nucleic acids from clinical samples using the polymerase chain reaction. J Med Virol (1989) 2.47
Acute local reactions after intraarticular hylan for osteoarthritis of the knee. J Rheumatol (1995) 2.37
Drug-induced myopathies in man. Lancet (1978) 2.25
Molecular analysis of human parechovirus type 2 (formerly echovirus 23). J Gen Virol (1998) 1.84
Acute cerebral oedema induced by methotrexate. BMJ (1989) 1.79
Reversion to neurovirulence of the live-attenuated Sabin type 3 oral poliovirus vaccine. Nucleic Acids Res (1984) 1.71
An RNA tertiary structure in the 3' untranslated region of enteroviruses is necessary for efficient replication. J Virol (1997) 1.67
The complete nucleotide sequence of enterovirus type 70: relationships with other members of the picornaviridae. J Gen Virol (1990) 1.64
Polymerase chain reaction amplification of rhinovirus nucleic acids from clinical material. Nucleic Acids Res (1988) 1.63
Screening for mitochondrial cytopathies: the sub-anaerobic threshold exercise test (SATET). J Neurol Neurosurg Psychiatry (1989) 1.56
Neurological presentations of hypothyroidism: the importance of slow relaxing reflexes. J R Soc Med (1995) 1.51
Glycine and neurodegenerative disease. Lancet (1991) 1.51
Molecular relationships between 21 human rhinovirus serotypes. J Gen Virol (1995) 1.50
Single-photon emission computed tomography using hexamethylpropyleneamine oxime in the prognosis of acute cerebral infarction. Stroke (1996) 1.47
Arginine-glycine-aspartic acid motif is critical for human parechovirus 1 entry. J Virol (2001) 1.46
The role of viscosupplementation with hylan G-F 20 (Synvisc) in the treatment of osteoarthritis of the knee: a Canadian multicenter trial comparing hylan G-F 20 alone, hylan G-F 20 with non-steroidal anti-inflammatory drugs (NSAIDs) and NSAIDs alone. Osteoarthritis Cartilage (1995) 1.45
A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 2. Laboratory results. J Neurol Neurosurg Psychiatry (1987) 1.42
Histological surprise: callosal tuberculoma presenting as malignant glioma. J Neurol Neurosurg Psychiatry (1997) 1.40
Construction of poliovirus intertypic recombinants by use of cDNA. J Virol (1986) 1.38
Adenosine inhibits and potentiates IgE-dependent histamine release from human lung mast cells by an A2-purinoceptor mediated mechanism. Biochem Pharmacol (1984) 1.38
Acute transverse myelitis and Guillain-Barré overlap syndrome with serological evidence for mumps viraemia. Acta Neurol Scand (2001) 1.38
Persistence of enteroviral RNA in chronic fatigue syndrome is associated with the abnormal production of equal amounts of positive and negative strands of enteroviral RNA. J Gen Virol (1990) 1.33
The genetic status of mothers of isolated cases of Duchenne muscular dystrophy. J Med Genet (1983) 1.32
Adenosine inhibits and potentiates IgE-dependent histamine release from human basophils by an A2-receptor mediated mechanism. Br J Pharmacol (1983) 1.29
Letter: Standardization of the E.S.R. Br Med J (1974) 1.28
Fundamental importance of arterial oxygen content in the regulation of cerebral blood flow in man. Brain (1985) 1.28
The clinical diagnosis of Alzheimer's disease. Arch Neurol (1987) 1.26
Purification of an inositol (1,3,4,5)-tetrakisphosphate 3-phosphatase activity from rat liver and the evaluation of its substrate specificity. J Biol Chem (1991) 1.15
Inositol hexakisphosphate in Schizosaccharomyces pombe: synthesis from Ins(1,4,5)P3 and osmotic regulation. Biochem J (1998) 1.15
Peripheral blood lymphocyte sub-populations and multiple sclerosis. J Neuroimmunol (1984) 1.13
The relationship between cyclic AMP changes and histamine release from basophil-rich human leucocytes. Biochem Pharmacol (1983) 1.12
The nucleotide sequence of a type 3 poliovirus isolated during a recent outbreak of poliomyelitis in Finland. J Gen Virol (1986) 1.11
Cytochrome c oxidase deficiency associated with the first stop-codon point mutation in human mtDNA. Am J Hum Genet (1998) 1.11
Adenosine potentiates immunological histamine release from rat mast cells by a novel cyclic AMP-independent cell-surface action. Br J Pharmacol (1985) 1.10
Studies on the receptor mediating cyclic AMP-independent enhancement by adenosine of IgE-dependent mediator release from rat mast cells. Br J Pharmacol (1986) 1.07
Lactate responses to exercise in chronic fatigue syndrome. J Neurol Neurosurg Psychiatry (1994) 1.05
Phytoestrogens are potent inhibitors of estrogen sulfation: implications for breast cancer risk and treatment. J Clin Endocrinol Metab (2004) 1.04
Botulinum toxin injection in the treatment of tennis elbow. A double-blind, randomized, controlled, pilot study. J Bone Joint Surg Am (2005) 1.02
No direct correlation between serum antiacetylcholine receptor antibody levels and clinical state of individual patients with myasthenia gravis. Neurology (1981) 1.01
'Cardiogenic dementia' revisited. J R Soc Med (1991) 1.00
In vivo and in vitro identification of structural and sequence elements of the human parechovirus 5' untranslated region required for internal initiation. J Virol (2000) 1.00
In vitro studies of fretting corrosion of orthopaedic materials. J Orthop Res (1988) 0.98
Familial cramp due to potassium-aggravated myotonia. J Neurol Neurosurg Psychiatry (1998) 0.98
Septic arthritis or transient synovitis of the hip in children: the value of clinical prediction algorithms. J Bone Joint Surg Br (2010) 0.96
Purification and characterization of inositol-1,3,4-trisphosphate 5/6-kinase from rat liver using an inositol hexakisphosphate affinity column. J Biol Chem (1992) 0.95
Risk of tuberculosis in Canada: implications for priorities in programs directed at specific groups. Can J Public Health (1988) 0.94
Intra-operative B-mode ultrasound scanning of the extra-hepatic biliary system and pancreas. Lancet (1980) 0.93
Low dose prednisone does not affect calcium homeostasis or bone density in postmenopausal women with rheumatoid arthritis. J Rheumatol (1991) 0.93
Reactivity of the cerebral circulation in patients with carotid occlusion. J Neurol Neurosurg Psychiatry (1986) 0.93
Operative ultrasonic features of insulinomas. Am J Surg (1982) 0.92
The range of the Oxford Shoulder Score in the asymptomatic population: a marker for post-operative improvement. Ann R Coll Surg Engl (2011) 0.92
Thalamic hemorrhages in Wernicke-Korsakoff syndrome demonstrated by computed tomography. Ann Neurol (1988) 0.92
Hyperammonaemia--an important cause of encephalopathy: three case reports. Ann Clin Biochem (1993) 0.91
Persistence of enterovirus RNA in muscle biopsy samples suggests that some cases of chronic fatigue syndrome result from a previous, inflammatory viral myopathy. J Med (1993) 0.90
Rhinovirus detection using probes from the 5' and 3' end of the genome. Arch Virol (1989) 0.90
Familial amyotrophic lateral sclerosis with a point mutation of SOD-1: intrafamilial heterogeneity of disease duration associated with neurofibrillary tangles. J Neurol Neurosurg Psychiatry (1995) 0.90
Oculomotor function in amyotrophic lateral sclerosis: evidence for frontal impairment. Ann Neurol (1995) 0.90
Pharmacokinetics of norfloxacin (MK 366) in patients with impaired kidney function--some preliminary results. J Antimicrob Chemother (1984) 0.89
Epsilon aminocaproic acid (EACA) myopathy. Postgrad Med J (1979) 0.88
Disease incidence and results of extremity lesion treatment: mersey region soft tissue sarcomas (1975-1985). Sarcoma (1998) 0.88
Polyneuropathy in occult hypothyroidism. Postgrad Med J (1983) 0.87
Pseudoaxonal Guillain-Barré syndrome: severe demyelination mimicking axonopathy. A case with pupillary involvement. J Neurol Neurosurg Psychiatry (1992) 0.86
Ultraviolet-laser ablation of skin. Arch Dermatol (1985) 0.86
Limitations of intra-arterial thrombolysis. Cardiovasc Surg (1997) 0.86
Repair of incompetent venous valves: a new technique. J Vasc Surg (1988) 0.86
The effect of three finishing systems on four esthetic restorative materials. Oper Dent (1998) 0.86
Cerebral blood flow and blood viscosity in patients with polycythaemia secondary to hypoxic lung disease. Br Med J (Clin Res Ed) (1981) 0.86
The interaction of lithium ions with inositol lipid signalling systems. Biochem Soc Trans (1987) 0.86
Do dietary phytoestrogens influence susceptibility to hormone-dependent cancer by disrupting the metabolism of endogenous oestrogens? Biochem Soc Trans (2001) 0.86
Suppressor T cells in family members of patients with multiple sclerosis. Brain (1986) 0.86
Postobstructive pulmonary oedema. Anaesth Intensive Care (2001) 0.86
Dermatomyositis in association with transitional cell carcinoma of the bladder. Clin Exp Dermatol (1999) 0.85
Thymectomy in late-onset myasthenia gravis. Arch Neurol (1982) 0.85
A double-blind, placebo-controlled, crossover study of verapamil in exertional muscle pain. Muscle Nerve (1986) 0.85
The relationship of spinal muscular atrophy to motor neuron disease: investigation of SMN and NAIP gene deletions in sporadic and familial ALS. J Neurol Sci (1997) 0.85
Measurement of phosphate concentration in the presence of very labile phosphate esters. Anal Biochem (1984) 0.84
An evaluation of some carrier detection techniques in Duchenne muscular dystrophy. J Neurol Sci (1979) 0.84
Bifrontal glioma presenting as a gross movement disorder. Mov Disord (1993) 0.83
A randomized controlled trial to evaluate the effectiveness of an exercise program in women with rheumatoid arthritis taking low dose prednisone. J Rheumatol (2000) 0.83
Electrocardiographic abnormalities in carriers of Duchenne muscular dystrophy. Neurology (1980) 0.83
Wildervanck or cervico-oculo-acoustic syndrome and MRI findings. J Neurol Neurosurg Psychiatry (1991) 0.83
Separate purinoceptors mediate enhancement by adenosine of concanavalin A-induced mediator release and the cyclic AMP response in rat mast cells. Agents Actions (1986) 0.82
Human temporomandibular joint and myofascial pain biochemical profiles: a case-control study. J Oral Rehabil (2012) 0.82
Nonfunctional paraganglioma of the larynx: clinical and pathological considerations. Cancer (1981) 0.82
Case Report: a patient with primary biliary cirrhosis and autoimmune hemolytic anemia. J Gastroenterol Hepatol (1996) 0.81
Rat testicular myoid cells express vasopressin receptors: receptor structure, signal transduction, and developmental regulation. Endocrinology (1995) 0.81
Hemoglobin concentration and prognosis in symptomatic obstructive cerebrovascular disease. Stroke (1987) 0.81
A clinical and genetic study of a manifesting heterozygote with X-linked myotubular myopathy. Neuromuscul Disord (2000) 0.81
A novel method of typing rhinoviruses using the product of a polymerase chain reaction. Arch Virol (1990) 0.80
Testosterone deficiency myopathy. J R Soc Med (1995) 0.80
Inositol lipid-mediated signalling in response to endothelin and ATP in the mammalian testis. Mol Cell Biochem (1996) 0.80
Pediatric infectious cervical lymphadenitis. Otolaryngol Head Neck Surg (1985) 0.80
Natural history of the spontaneous reperfusion of human cerebral infarcts as assessed by 99mTc HMPAO SPECT. J Neurol Neurosurg Psychiatry (1998) 0.80
Aneurysm of the internal carotid artery at the base of the skull: an unusual cause of cranial neuropathies. Otolaryngol Head Neck Surg (1979) (1980) 0.79